Borderline Tumors and Low-Grade Serous Ovarian Cancer: The Connection

If you've been diagnosed with a borderline ovarian tumor, you may have heard the term low-grade serous ovarian cancer come up in conversation with your doctor. But what exactly is the connection between the two? In this video, Dr. David M. Gershenson, Professor of Gynecologic Oncology and Reproductive Medicine at MD Anderson Cancer Center, breaks down the relationship between borderline ovarian tumors and LGSOC, and why understanding this connection matters for your care. Borderline ovarian tumors, also called BOTs, are not outright malignant, but they are not entirely benign either. Research has shown that in some cases, they can serve as a precursor to low-grade serous ovarian cancer, making it important for patients and their families to understand the risks and what to watch for over time. Key points Dr. Gershenson covers in this video: The binary grading system for serous carcinoma The biological relationship between borderline ovarian tumors and LGSOC How BOTs can progress and what factors influence that risk Whether you are newly diagnosed with a borderline tumor or trying to better understand your LGSOC diagnosis, this is essential information. Learn more about borderline ovarian tumors: https://www.nottheseovaries.org/borde... Learn more about low-grade serous ovarian cancer: https://www.nottheseovaries.org/low-g... Support ovarian cancer research at Not These Ovaries: https://www.nottheseovaries.org/fund-... #OvarianCancer #LGSOC #LowGradeSerousOvarianCancer #BorderlineOvarianTumor #BOT #OvarianCancerAwareness #GynecologicCancer #WomensHealth #CancerResearch #OvarianCancerDiagnosis #MDAndersonCancerCenter #NotTheseOvaries